chrX-153905524-C-T

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate

The NM_000054.7(AVPR2):​c.26-8C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000254 in 1,179,332 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., 1 hem., cov: 24)
Exomes 𝑓: 9.4e-7 ( 0 hom. 0 hem. )

Consequence

AVPR2
NM_000054.7 splice_region, intron

Scores

2
Splicing: ADA: 0.00008247
2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.37

Publications

0 publications found
Variant links:
Genes affected
AVPR2 (HGNC:897): (arginine vasopressin receptor 2) This gene encodes the vasopressin receptor, type 2, also known as the V2 receptor, which belongs to the seven-transmembrane-domain G protein-coupled receptor (GPCR) superfamily, and couples to Gs thus stimulating adenylate cyclase. The subfamily that includes the V2 receptor, the V1a and V1b vasopressin receptors, the oxytocin receptor, and isotocin and mesotocin receptors in non-mammals, is well conserved, though several members signal via other G proteins. All bind similar cyclic nonapeptide hormones. The V2 receptor is expressed in the kidney tubule, predominantly in the distal convoluted tubule and collecting ducts, where its primary property is to respond to the pituitary hormone arginine vasopressin (AVP) by stimulating mechanisms that concentrate the urine and maintain water homeostasis in the organism. When the function of this gene is lost, the disease Nephrogenic Diabetes Insipidus (NDI) results. The V2 receptor is also expressed outside the kidney although its tissue localization is uncertain. When these 'extrarenal receptors' are stimulated by infusion of a V2 selective agonist (dDAVP), a variety of clotting factors are released into the bloodstream. The physiologic importance of this property is not known - its absence does not appear to be detrimental in NDI patients. The gene expression has also been described in fetal lung tissue and lung cancer associated with alternative splicing. [provided by RefSeq, Jul 2008]
AVPR2 Gene-Disease associations (from GenCC):
  • diabetes insipidus, nephrogenic, X-linked
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • nephrogenic syndrome of inappropriate antidiuresis
    Inheritance: XL Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • nephrogenic diabetes insipidus
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant X-153905524-C-T is Benign according to our data. Variant chrX-153905524-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 2802324.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AVPR2NM_000054.7 linkc.26-8C>T splice_region_variant, intron_variant Intron 2 of 3 ENST00000646375.2 NP_000045.1 P30518-1
AVPR2NM_001146151.3 linkc.26-8C>T splice_region_variant, intron_variant Intron 2 of 2 NP_001139623.1 P30518-2
AVPR2NR_027419.2 linkn.465+354C>T intron_variant Intron 2 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AVPR2ENST00000646375.2 linkc.26-8C>T splice_region_variant, intron_variant Intron 2 of 3 NM_000054.7 ENSP00000496396.1 P30518-1
ENSG00000284987ENST00000646191.1 linkn.96+3546G>A intron_variant Intron 1 of 4 ENSP00000493873.1 A0A2R8Y4P6

Frequencies

GnomAD3 genomes
AF:
0.0000177
AC:
2
AN:
112684
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.0000644
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
9.38e-7
AC:
1
AN:
1066648
Hom.:
0
Cov.:
29
AF XY:
0.00
AC XY:
0
AN XY:
345766
show subpopulations
African (AFR)
AF:
0.0000392
AC:
1
AN:
25511
American (AMR)
AF:
0.00
AC:
0
AN:
31331
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18849
East Asian (EAS)
AF:
0.00
AC:
0
AN:
28387
South Asian (SAS)
AF:
0.00
AC:
0
AN:
51199
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
37658
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3365
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
825532
Other (OTH)
AF:
0.00
AC:
0
AN:
44816
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000177
AC:
2
AN:
112684
Hom.:
0
Cov.:
24
AF XY:
0.0000287
AC XY:
1
AN XY:
34838
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000644
AC:
2
AN:
31061
American (AMR)
AF:
0.00
AC:
0
AN:
10790
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2659
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3562
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2780
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6257
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
238
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53136
Other (OTH)
AF:
0.00
AC:
0
AN:
1519
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.325
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000151

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Nov 05, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.97
DANN
Benign
0.44
PhyloP100
-1.4
PromoterAI
-0.019
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000082
dbscSNV1_RF
Benign
0.0060
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1294506713; hg19: chrX-153170978; API